Bayer AG (XTER:BAYN)
€ 24.08 -0.285 (-1.17%) Market Cap: 23.66 Bil Enterprise Value: 55.94 Bil PE Ratio: 0 PB Ratio: 0.66 GF Score: 67/100

Bayer AG to Discuss Agreements to Resolve Major Legacy Monsanto Litigation Investor Conference Call Transcript

Jun 24, 2020 / 06:00PM GMT
Release Date Price: €69.99 (-3.60%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to Bayer's Investor and Analyst Conference Call on June 24. (Operator Instructions) I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations of Bayer AG. Please go ahead, sir.

Oliver Maier
Bayer Aktiengesellschaft - Head of IR

Emma, thank you so much. I appreciate it. Thank you, everybody, for joining today's briefing call about the announcement Bayer just made just a short while ago regarding a series of agreements that will substantially resolve legacy Monsanto litigation, including Roundup, dicamba and PCB.

We have with us today our CEO, Werner Baumann; our CFO, Wolfgang Nickl; we have Liam Condo, President for Crop Science and Board of management; Bill Dodero, our Global Head of Litigation for Bayer.

You should have all received our press release announcing the resolution. (Operator Instructions)

As always, I would like to start the call today by drawing your attention to the cautionary language that is included in our safe harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot